Cerebrospinal Fluid Biomarkers of Neuronal/Glial Damage or Immune Activation Are Unsuitable for Assessing Post-COVID Cognitive Impairment
- PMID: 38036417
- DOI: 10.1093/infdis/jiad548
Cerebrospinal Fluid Biomarkers of Neuronal/Glial Damage or Immune Activation Are Unsuitable for Assessing Post-COVID Cognitive Impairment
Conflict of interest statement
Potential conflicts of interest. Author certifies no potential conflicts of interest. The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Comment in
-
Reply to Finsterer.J Infect Dis. 2024 Mar 14;229(3):920-921. doi: 10.1093/infdis/jiad549. J Infect Dis. 2024. PMID: 38036488 No abstract available.
Comment on
-
COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.J Infect Dis. 2024 Feb 14;229(2):493-501. doi: 10.1093/infdis/jiad395. J Infect Dis. 2024. PMID: 37874918 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
